{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:40:50Z","timestamp":1788907250509,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360805"],"award-info":[{"award-number":["82360805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["TGY24H030008"],"award-info":[{"award-number":["TGY24H030008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["Q24H280064"],"award-info":[{"award-number":["Q24H280064"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116111","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:12:24Z","timestamp":1766981544000},"page":"116111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases"],"prefix":"10.1016","volume":"170","author":[{"given":"Weifeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiluo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.116111_bb0005","doi-asserted-by":"crossref","first-page":"106333","DOI":"10.1016\/j.nbd.2023.106333","article-title":"Research progress on pyroptosis and its effect on the central nervous system","volume":"188","author":"Hao","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2025.116111_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113006","article-title":"Inflammation unleashed: the role of pyroptosis in chronic liver diseases","volume":"141","author":"Zhu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.116111_bb0015","doi-asserted-by":"crossref","first-page":"1449969","DOI":"10.3389\/fimmu.2024.1449969","article-title":"Inflammasomes and idiopathic inflammatory myopathies","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116111_bb0020","doi-asserted-by":"crossref","first-page":"1513206","DOI":"10.3389\/fimmu.2024.1513206","article-title":"Regulation of ubiquitination in sepsis: from PAMP versus DAMP to peripheral inflammation and cell death","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116111_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102723","article-title":"TLR\/NLRP3 inflammasome signaling pathways as a main target in frailty, cachexia and sarcopenia","volume":"93","author":"Shahbaz","year":"2025","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0030","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms24043067","article-title":"The role of the NLRP3 inflammasome and programmed cell death in acute liver injury","volume":"24","author":"Yu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.116111_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.09.007","article-title":"Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors","volume":"74","author":"Ye","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.116111_bb0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2025.116111_bb0045","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/biom14080978","article-title":"Mechanism of reactive oxygen species-guided immune responses in gouty arthritis and potential therapeutic targets","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/thorax-2024-222596","article-title":"Role of inflammasomes in acute respiratory distress syndrome","volume":"80","author":"Flower","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2025.116111_bb0060","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2147\/JIR.S464838","article-title":"Acute lung injury and the NLRP3 inflammasome","volume":"17","author":"Gu","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.116111_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2025.116111_bb0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116111_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","article-title":"Inflammasome components as new therapeutic targets in inflammatory disease","volume":"25","author":"Coll","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.116111_bb0080","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1142\/S0192415X22500847","article-title":"Arteannuin B enhances the effectiveness of cisplatin in non-small cell lung Cancer by regulating connexin 43 and MAPK pathway","volume":"50","author":"Huang","year":"2022","journal-title":"Am. J. Chin. Med."},{"issue":"22","key":"10.1016\/j.intimp.2025.116111_bb0085","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.3390\/molecules27228068","article-title":"Arteannuin-B and (3-chlorophenyl)-2-Spiroisoxazoline derivative exhibit anti-inflammatory effects in LPS-activated RAW 264.7 macrophages and BALB\/c mice-induced proinflammatory responses via downregulation of NF-\u03baB\/P38 MAPK signaling","volume":"27","author":"Sawhney","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0090","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41401-023-01212-5","article-title":"Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice","volume":"45","author":"Shao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.intimp.2025.116111_bb0095","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41418-023-01148-7","article-title":"Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3","volume":"30","author":"Liu","year":"2023","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0100","first-page":"C645","article-title":"The role of cl- and K+ efflux in NLRP3 inflammasome and innate immune response activation","volume":"322","author":"Koumangoye","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"2","key":"10.1016\/j.intimp.2025.116111_bb0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.apsb.2022.09.014","article-title":"Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.intimp.2025.116111_bb0110","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.116111_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1197","article-title":"Pyroptosis and polarization of macrophages in septic acute lung injury induced by lipopolysaccharide in mice","volume":"12","author":"Zhou","year":"2024","journal-title":"Immun Inflamm Dis"},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00011-023-01705-3","article-title":"RBM3 is associated with acute lung injury in septic mice and patients via the NF-\u03baB\/NLRP3 pathway","volume":"72","author":"Long","year":"2023","journal-title":"Inflamm. Res."},{"issue":"7","key":"10.1016\/j.intimp.2025.116111_bb0125","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.116111_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2025.116111_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00210-020-02035-5","article-title":"NF-\u03baB signalling as a pharmacological target in COVID-19: potential roles for IKK\u03b2 inhibitors","volume":"394","author":"Kandasamy","year":"2021","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"7512","key":"10.1016\/j.intimp.2025.116111_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Vande Walle","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.116111_bb0145","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41467-024-44990-0","article-title":"Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1\u03b2 production","volume":"15","author":"Molina-L\u00f3pez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.116111_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156432","article-title":"Norwogonin attenuates LPS-induced acute lung injury through inhibiting Src\/AKT1\/NF-\u03baB signaling pathway","volume":"139","author":"Cao","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2025.116111_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114047","article-title":"Unveiling the role of PD-L1 in vascular endothelial dysfunction: insights into the mtros\/NLRP3\/caspase-1 mediated pyroptotic pathway","volume":"438","author":"Tao","year":"2024","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.116111_bb0160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20180282","article-title":"TAK1ng control: TAK1 restrains NLRP3 activation","volume":"215","author":"Mangan","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.116111_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.apha.2024.10.004","article-title":"Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors","volume":"102","author":"Kaur","year":"2025","journal-title":"Adv. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925021009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925021009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:59:54Z","timestamp":1771520394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925021009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":33,"alternative-id":["S1567576925021009"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116111","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116111"}}